MedTrace Logo

ADSC Injections for Pain Management of Osteoarthritis in the Human Knee Joint

NCT02357485 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2015-06-30

Study results available
· View outcomes & findings →

Summary

This safety and feasibility study used autologous adipose-derived stromal cells (ADSC), the stromal vascular fraction (SVF), to treat 8 osteoarthritic (OA) knees in 6 patients of grade I to III (K-L scale) with initial pain of 4 or greater on a 10 point scale, under Institutional Review Board (IRB) approved protocol.

Conditions

  • Osteoarthritis of the Knee

Interventions

BIOLOGICAL

ADSC

Single injection of ADSC

Sponsors & Collaborators

  • Plastic Surgery Education and Research Foundation

    collaborator UNKNOWN

  • Fodor, Peter B, M.D.

    lead INDIV

Principal Investigators

  • Peter B Fodor, M.D. · Private Practice

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2015-05-31
Completion
2015-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02357485 on ClinicalTrials.gov